Listed
Stock Code: 018680
| Company Name | (주)서울제약 |
| English Name | SEOUL PHARMA CO.,LTD |
| Business Reg. No. | 1338130405 |
| CEO | 윤동현, 신봉환 (각자대표) |
| Address | 충청북도 청주시 흥덕구 오송읍 오송생명6로 124-31 서울제약 오송공장 |
| Industry | 의약품 제조업 |
| Industry Code | 212 |
| Established | 19851223 |
| Phone | 02-3470-2300 |
| Website | www.seoulpharma.com |
| Regular Employees | 175persons |
| Corp. Reg. No. | 1301110008721 |
Revenue CAGR +9.8%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 536B | 525B | 501B | 405B |
| Operating Profit | 15B | 12B | 17B | -57B |
| Net Profit | 17B | 35B | 8.6B | -97B |
| Total Assets | 716B | 633B | 624B | 623B |
| Total Liabilities | 314B | 247B | 270B | 433B |
| Total Equity | 402B | 386B | 354B | 190B |
▲ 12.4%
▲ 265.9%
▲ 202.6%
▼ 36.3%
▲ 132.1%
| Name | Position | Role |
|---|---|---|
| 윤동현 | 사내이사 | CEO |
| 이정율 | 미등기 | 영업 총괄 |
| 김현수 | 미등기 | 연구 |
| 임위준 | 미등기 | 개발 |
| 신봉환 | 사내이사 | CEO |
| 손명기 | 사내이사 | 자문 |
| 황희연 | 기타비상무이사 | 자문 |
| 박규식 | 사외이사 | 자문 /감독 |
| 한명수 | 사외이사 | 자문 /감독 |
| 박강규 | 감사 | 감사 |
| 최승호 | 미등기 | 생산 |
| 이세용 | 미등기 | CFO |
| NPS Subscribers | 125persons |
| CEO | 윤동현, 신봉환 (각자대표) |
| Est. Avg. Annual Salary | 4,71810K (39310K/mo) |
| Hired (12 mo) | +5persons |
| Left (12 mo) | -2persons |
| Net Change (12 mo) | +3persons |
| NPS Join Date | 1988-01-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
1 Additional Data Sources
{
"address": "충청북도 청주시 흥덕구 오송읍 오송생명6로",
"brno": "133813****",
"cappedWarning": false,
"companyName": "(주)서울제약",
"estimatedAvgAnnualSalary": 47184672,
"estimatedAvgMonthlySalary": 3932056,
"fetchedAt": "2026-03-05T13:36:21.907Z",
"industryCode": "242301",
"industryName": "완제 의약품 제조업",
"joinDate": "19880101",
"last12MonthsHired": 5,
"last12MonthsLeft": 2,
"last12MonthsNetChange": 3,
"leaveDate": null,
"monthlyPensionAmount": 46693160,
"monthlyTrend": [
{
"lostSubscribers": 2,
"newSubscribers": 5,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6398462",
"status": "1",
"styleCode": "1",
"subscriberCount": 125,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 7/7
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| SME Status Info | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |